title: Can we avoid treatment interruption studies in the search for an HIV cure?
authors.affiliation: aUnité Fonctionnelle de Thérapeutique en Immuno-Infectiologie, Centre Hospitalier Universitaire Hôtel Dieu, Hôpitaux de Paris bNecker School of Medicine, Paris Descartes University, Sorbonne-Paris-Cité cLaboratoire de Virologie, Hôpitaux de Paris, Hôpital Saint-Louis dUniversité Paris Diderot, Sorbonne Paris Cité eINSERM U941, Hôpital Saint-Louis, Paris, France.
authors.forename: Jade
authors.initials: J
authors.lastname: Ghosn
authors.forename: Constance
authors.initials: C
authors.lastname: Delaugerre
mesh_terms: D044966:Anti-Retroviral Agents / Q000008:administration & dosage*; D015415:Biomarkers; D016903:Drug Monitoring / Q000379:methods*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D028761:Withholding Treatment
chemical_list: D044966:Anti-Retroviral Agents; D015415:Biomarkers